CD163 and cancer: These fusion processes in vitro and in vivo demonstrated acquisition of macrophage-like properties in the hybrid cancer cells, including expression of the transmembrane adapter protein DAP12 and the macrophage-specific scavenger receptor CD163, which was also detectable in cancer cells of clinical tumor specimen [38,39].